Executives On The Move: Research And Clinical Management Changes At Lundbeck, Sangamo And Angion
Executive Summary
Research and clinical are in the spotlight this week with new EVP, R&D leaders at global CNS pharma Lundbeck and gene-based therapeutics firm Sangamo. And Angion Biomedica, a kidney disease biopharma, announces its new SVP, CMO.